Is This Rare Berkshire Hathaway Miscue Finally a Buy?
Berkshire Hathaway cut bait with the struggling drugmaker Teva Pharmaceutical Industries in late 2021.
Is This Rare Berkshire Hathaway Miscue Finally a Buy?
Berkshire Hathaway cut bait with the struggling drugmaker Teva Pharmaceutical Industries in late 2021.